KPX Chemical Co.,Ltd. (KRX:025000)
South Korea
· Delayed Price · Currency is KRW 43,600
-50 (-0.11%)
At close: Mar 26, 2025, 3:30 PM KST
KPX Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 913,367 | 911,120 | 983,580 | 1,020,786 | 746,662 | Upgrade
|
| Other Revenue | - | -0 | - | -0 | - | Upgrade
|
| Revenue | 913,367 | 911,120 | 983,580 | 1,020,786 | 746,662 | Upgrade
|
| Revenue Growth (YoY) | 0.25% | -7.37% | -3.65% | 36.71% | -2.49% | Upgrade
|
| Cost of Revenue | 766,322 | 768,869 | 837,782 | 900,138 | 625,867 | Upgrade
|
| Gross Profit | 147,045 | 142,251 | 145,797 | 120,648 | 120,796 | Upgrade
|
| Selling, General & Admin | 90,685 | 78,362 | 94,662 | 72,195 | 53,074 | Upgrade
|
| Other Operating Expenses | 1,567 | 1,730 | 1,374 | 1,458 | 1,769 | Upgrade
|
| Operating Expenses | 101,614 | 83,864 | 99,284 | 75,967 | 56,678 | Upgrade
|
| Operating Income | 45,430 | 58,387 | 46,513 | 44,680 | 64,118 | Upgrade
|
| Interest Expense | -3,534 | -3,488 | -2,316 | -1,250 | -538.36 | Upgrade
|
| Interest & Investment Income | 9,056 | 8,121 | 6,768 | 7,331 | 5,571 | Upgrade
|
| Earnings From Equity Investments | 5,156 | 8,133 | -1,290 | 3,462 | 439.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 2,935 | -2,038 | 560.63 | 2,846 | -1,899 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,744 | 1,100 | 3,406 | 1,517 | 494.85 | Upgrade
|
| EBT Excluding Unusual Items | 62,786 | 70,214 | 53,641 | 58,587 | 68,186 | Upgrade
|
| Gain (Loss) on Sale of Investments | 19,602 | 14,162 | -16,386 | 5,593 | 15,272 | Upgrade
|
| Gain (Loss) on Sale of Assets | -666.81 | -212.64 | 149.46 | 22.14 | -0.66 | Upgrade
|
| Asset Writedown | - | - | - | - | 58 | Upgrade
|
| Pretax Income | 81,721 | 84,163 | 37,405 | 64,202 | 83,515 | Upgrade
|
| Income Tax Expense | 17,854 | 18,385 | 7,837 | 14,954 | 19,099 | Upgrade
|
| Earnings From Continuing Operations | 63,868 | 65,778 | 29,568 | 49,248 | 64,416 | Upgrade
|
| Minority Interest in Earnings | 347.38 | -901.31 | -964.73 | -1,111 | -1,138 | Upgrade
|
| Net Income | 64,215 | 64,877 | 28,603 | 48,137 | 63,278 | Upgrade
|
| Net Income to Common | 64,215 | 64,877 | 28,603 | 48,137 | 63,278 | Upgrade
|
| Net Income Growth | -1.02% | 126.82% | -40.58% | -23.93% | 51.92% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | -0.00% | 0.00% | - | - | - | Upgrade
|
| EPS (Basic) | 13504.00 | 13643.00 | 6015.16 | 10123.02 | 13306.99 | Upgrade
|
| EPS (Diluted) | 13504.00 | 13643.00 | 6015.16 | 10123.02 | 13306.99 | Upgrade
|
| EPS Growth | -1.02% | 126.81% | -40.58% | -23.93% | 51.92% | Upgrade
|
| Free Cash Flow | 43,633 | 60,663 | 24,600 | -36,125 | 87,999 | Upgrade
|
| Free Cash Flow Per Share | 9175.83 | 12756.83 | 5173.21 | -7596.90 | 18505.73 | Upgrade
|
| Dividend Per Share | - | - | 2750.000 | 2750.000 | 2750.000 | Upgrade
|
| Dividend Growth | - | - | - | - | 10.00% | Upgrade
|
| Gross Margin | 16.10% | 15.61% | 14.82% | 11.82% | 16.18% | Upgrade
|
| Operating Margin | 4.97% | 6.41% | 4.73% | 4.38% | 8.59% | Upgrade
|
| Profit Margin | 7.03% | 7.12% | 2.91% | 4.72% | 8.48% | Upgrade
|
| Free Cash Flow Margin | 4.78% | 6.66% | 2.50% | -3.54% | 11.79% | Upgrade
|
| EBITDA | 72,461 | 84,410 | 68,023 | 62,639 | 80,769 | Upgrade
|
| EBITDA Margin | 7.93% | 9.26% | 6.92% | 6.14% | 10.82% | Upgrade
|
| D&A For EBITDA | 27,031 | 26,023 | 21,510 | 17,958 | 16,651 | Upgrade
|
| EBIT | 45,430 | 58,387 | 46,513 | 44,680 | 64,118 | Upgrade
|
| EBIT Margin | 4.97% | 6.41% | 4.73% | 4.38% | 8.59% | Upgrade
|
| Effective Tax Rate | 21.85% | 21.84% | 20.95% | 23.29% | 22.87% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.